GlassScriptPhysician profile
Timothy C Trageser
NPI 1972507929
$5,546.74
in general payments reported to CMS, 2019-2025
20 companies · $1,111 in 2025
The $1,111 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $384 · 2021: $692 · 2022: $1,119 · 2023: $817 · 2024: $675 · 2025: $1,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,196.74 | 2019-2025 | Impella |
| Boston Scientific Corporation | $594.93 | 2019-2025 | General - Balloon Catheters, Innova Vascular, Synergy |
| Stryker Corporation | $212.11 | 2025 | Artix Mt, Flowtriever |
| Shockwave Medical, INC | $208.90 | 2021-2025 | |
| Inari Medical, INC. | $206.93 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $188.40 | 2024-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $165.70 | 2021-2023 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $162.18 | 2019 | |
| Amgen INC. | $142.60 | 2022-2025 | Repatha |
| Pfizer INC. | $87.01 | 2024-2025 | |
| Abbott Laboratories | $83.40 | 2019-2025 | Navitor, Xience Skypoint, Diamondback Coronary |
| W. L. Gore & Associates, INC. | $67.23 | 2020-2022 | |
| Edwards Lifesciences Corporation | $54.46 | 2022 | |
| Bridgebio Pharma, INC. | $45.01 | 2025 | Attruby |
| Teleflex LLC | $32.97 | 2022-2024 | Pronto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $25.87 | 2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.14 | 2024 | Jardiance |
| Amarin Pharma, INC. | $19.88 | 2020 | |
| Penumbra, INC. | $16.10 | 2023 | Indigo System |
| Janssen Pharmaceuticals, INC | $14.18 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Trageser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.